Contemporary outcomes of bladder carcinoma in situ treated with an adequate bacille Calmette–Guérin immunotherapy,BJU International

当前位置： X-MOL 学术 › BJU Int. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Contemporary outcomes of bladder carcinoma in situ treated with an adequate bacille Calmette–Guérin immunotherapy
BJU International ( IF 4.5 ) Pub Date : 2021-08-10 , DOI: 10.1111/bju.15567
José Daniel Subiela _{1,

2} , Óscar Rodríguez Faba ₁ , Júlia Aumatell ₁ , Julio Calderón ₁ , Asier Mercadé ₁ , Josep Balañà ₁ , Cristina Esquinas ₃ , Ferran Algaba ₄ , Alberto Breda ₁ , Joan Palou ₁

Affiliation

To assess whether bacillus Calmette–Guérin (BCG) responsiveness after initiation of an adequate BCG treatment (at least five of six instillations of induction and at least two of three instillations of maintenance) impacts oncological outcomes in patients with carcinoma in situ (CIS) of the bladder treated with BCG immunotherapy.

中文翻译：